Cargando…
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Cancer immunotherapy works by stimulating and strengthening the body’s anti-tumor immune response to eliminate cancer cells. Over the past few decades, immunotherapy has shown remarkable efficacy in the treatment of cancer, particularly the success of immune checkpoint blockade targeting CTLA-4, PD-...
Autores principales: | Zhang, Zheying, Lu, Manman, Qin, Yu, Gao, Wuji, Tao, Li, Su, Wei, Zhong, Jiateng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085349/ https://www.ncbi.nlm.nih.gov/pubmed/33936118 http://dx.doi.org/10.3389/fimmu.2021.672356 |
Ejemplares similares
-
Study on the role of transcription factor SPI1 in the development of glioma
por: Du, Baoshun, et al.
Publicado: (2022) -
T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022) -
Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019) -
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017) -
Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)